Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder
Serotonin receptors of the 5-HT2 type were studied on platelet membranes from 15 patients suffering from major depression. Receptor binding and clinical state (assessed by the Hamilton and Beck rating scales) were examined in a drug free state upon admission and after 1 and 3 weeks of treatment with the antidepressant maprotiline (MPT). 5-HT2 receptor binding changed in correlation with changes in the clinical state of the patients as judged by the rating scales. Since most patients showed a clinical improvement, the patients as a group exhibited a significant decrease in binding concomitant with a drop in depression scores. However, in those patients in whom there was no clinical change or an increase in depression scores, 5-HT2 receptor binding did not change or increased, respectively, thus resulting in a significant correlation between clinical changes and changes in binding. These results support the use of 5-HT2 receptors on platelets in evaluating depression and its treatment.
Key wordsSerotonin Platelets Depression 5-HT2 receptors Maprotiline
- American Psychiatric Association Committee on Nomenclature and Statistics (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Washington DCGoogle Scholar
- Asberg M, Traskman L, Thoren P, Bertilsson L, Ringberger VA (1976) Serotonin depression — a biochemical subgroup within the affective disorders? Science 191:478–480Google Scholar
- Biegon A, Grinspoon A, Blumenfelt B, Bleich A, Apter A, Mester R (1990) Increased serotonin 5-HT2 receptor binding on blood platelets of suicidal men. Psychopharmacology 100:165–167Google Scholar